Our study points to the possibility that Treg-suppressing drugs, such as cyclosporine, may not be suitable for use in nodal PTCL patients with a reduced quantity of FoxP3+ cells. The gene discussed is FOXP3; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.